A recent study has found that one in six people who are independent at 3 months after stroke deteriorate and need assistance by 12 months. Older women with comorbidities, and patients not given appropriate secondary stroke prevention were most at risk. Anticipation and prevention of deterioration could help reduce the later burden of stroke.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Katzan, I. L. et al. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 918–944 (2014).
Ullberg, T., Zia, E., Petersson, J. & Norrving, B. Changes in functional outcome over the first year after stroke: an observational study from the Swedish Stroke Register. Stroke 46, 389–394 (2015).
Ovbiagele, B., Lyden, P. D. & Saver, J. L. Disability status at 1 month is a reliable proxy for final ischemic stroke outcome. Neurology 75, 688–692 (2010).
Intercollegiate Stroke Working Party. National clinical guideline for stroke [online], (2012).
Thrift, A. G. et al. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke. Stroke 45, 539–544 (2014).
Park, J.-H. & Ovbiagele, B. Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology 84, 50–56 (2015).
McGrath, E. R., Eikelboom, J. W., Kapral, M. K. & O'Donnell, M. J., Novel oral anticoagulants: a focused review for stroke physicians. Int. J. Stroke 9, 71–78 (2014).
Turner, M. et al. The impact of stroke unit care on outcome in a Scottish stroke population, taking into account case mix and selection bias. J. Neurol. Neurosurg. Psychiatry 86, 314–318 (2015).
Dorman, P., Waddell, F., Slattery, J., Dennis, M. & Sandercock, P. Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate and unbiased? Stroke 28, 1883–1887 (1997).
Sandercock, P. et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol. Assess. 6, 1–112 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
MacLeod, M., Turner, M. Stroke outcomes after 90 days—out of sight, out of mind?. Nat Rev Neurol 11, 187–188 (2015). https://doi.org/10.1038/nrneurol.2015.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.28